Search Within

Nayan Jain

Formats
  1. Meeting Abstract (6)
  2. Journal Article (4)
Groups
  1. Alumni (GSK) (10)
  2. Center for Hematologic Malignancies (10)
  3. Department of Medicine (10)
  4. GSK Faculty (10)
  5. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (10)
  6. Hematologic Malignancies Research (10)

More Groups

People
  1. Michel Sadelain (10)
  2. Michael Lopez (7)
  3. Richard Koche (7)
  4. Zeguo Zhao (7)
  5. Anton Dobrin (6)
  6. Archana Iyer (4)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (2)
  5. 2021 (2)
  6. 2020 (1)
Publications
  1. Cancer Research (2)
  2. Molecular Therapy (2)
  3. Blood (1)
  4. Cancer Discovery (1)
  5. Human Gene Therapy (1)
  6. Nature (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. Nature Publishing Group (3)
  3. American Society of Hematology (1)
  4. Mary Ann Liebert, Inc (1)
  5. Massachusetts Medical Society (1)
  6. Nature Research (1)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD4+ T-cell lymphoma harboring a chimeric antigen receptor integration in TP53
    Journal Article

    Perica, K.; Jain, N.; Scordo, M.; Patel, R.; Eren, O. C.; Patel, U.; Gundem, G.; Domenico, D.; Mitra, S.; Socci, N. D.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies
    Journal Article

    Dobrin, A.; Lindenbergh, P. L.; Shi, Y.; Perica, K.; Xie, H.; Jain, N.; Chow, A.; Wolchok, J. D.; Merghoub, T.; Sadelain, M.; more...
    Nature Cancer (2024)

    Fulltext@MSK | Save
  • Disruption of SUV39H1-mediated H3K9 methylation sustains CAR T-cell function
    Journal Article

    Jain, N.; Zhao, Z.; Koche, R. P.; Antelope, C.; Gozlan, Y.; Montalbano, A.; Brocks, D.; Lopez, M.; Dobrin, A.; Shi, Y.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Synthetic dual-costimulation for TCR and TCR-like targeted cell therapies
    Meeting Abstract

    Dobrin, A.; Xie, H.; Perica, K.; Jain, N.; Sadelain, M.; Hamieh, M.
    Human Gene Therapy (2023)

    Fulltext@MSK | Save
  • TET2 guards against unchecked BATF3-induced CAR T cell expansion
    Journal Article

    Jain, N.; Zhao, Z.; Feucht, J.; Koche, R.; Iyer, A.; Dobrin, A.; Mansilla-Soto, J.; Yang, J.; Zhan, Y.; Lopez, M.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • SUV39H1 disruption enhances the persistence and anti-tumor efficacy of CD28-costimulated human CAR T cells
    Meeting Abstract

    Jain, N.; Zhao, Z.; Koche, R.; Gozlan, Y.; Brocks, D.; Raveh-Sadka, T.; Wells, D.; Dobrin, A.; Shi, Y.; Lopez, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Disruption of H3K9me3-mediated gene silencing augments CAR T cell functional persistence
    Meeting Abstract

    Jain, N.; Zhao, Z.; Koche, R.; Gozlan, Y.; Brocks, D.; Raveh-Sadka, T.; Wells, D.; Dobrin, A.; Shi, Y.; Lopez, M.; more...
    Molecular Therapy (2022)

    Fulltext@MSK | Save
  • Emergence of a hyper-proliferative phenotype in TET2 edited human CAR T cells
    Meeting Abstract

    Jain, N.; Zhao, Z.; Iyer, A.; Lopez, M.; Feucht, J.; Koche, R.; Yang, J.; Zhan, Y.; Sadelain, M.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • CAR design and expression determine hyper-proliferative states in TET2 deficient T cells
    Meeting Abstract

    Jain, N.; Zhao, Z.; Iyer, A.; Lopez, M.; Feucht, J.; Koche, R.; Yang, J.; Zhan, Y.; Sadelain, M.
    Molecular Therapy (2021)

    Fulltext@MSK | Save
  • Loss of (TET2) uncouples proliferative and effector functions in CAR T cells
    Meeting Abstract

    Jain, N.; Zhao, Z.; Iyer, A. S.; Lopez, M.; Feucht, J.; Koche, R. P.; Zhan, Y.; Sadelain, M.
    Blood (2020)

    Fulltext@MSK | Save